The Texas Racing Commission has authorized the Texas Medical Diagnostic Laboratory to increase the amount of ELISA tests it conducts and decrease the number of screens it evaluates from urine samples collected for post-race analysis.
The Kentucky Equine Drug Research Council met Thursday at Keeneland to discuss options to identify and enforce the prohibited use of erythropoietin (EPO).
The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.
Most Popular Stories
- Horse of the Year Charismatic Dies
- Classic Empire Out of Fountain of Youth
- Epicharis Earns Japan's Kentucky Derby Bid
- Zakaroff 48-1 Stunner in El Camino Real Derby
- Lucky Pulpit, Sire of 'Chrome', Dies of a Heart Attack
- Mo Town Set for 3-Year-Old Debut in Risen Star
- Gold Dream Punches Ticket to BC Classic
- Royal Delta Half Brother Scores on Gulfstream Turf
- Terra Promessa Goes Gate to Wire in Bayakoa
- Cuddle Alert Gives Sire Bedford Falls First Stakes Win